Search Results - Zhangjun Cheng
- Showing 1 - 12 results of 12
-
1
-
2
Hsa_circ_0074298 promotes pancreatic cancer progression and resistance to gemcitabine by sponging miR-519 to target SMOC by Hong, Chen, Lishan, Wang, Peng, Xie, Zhengqing, Lei, Yang, Yang, Fangfang, Hu, Zeqian, Yu, Zhangjun, Cheng, Jiahua, Zhou
Published 2022Text -
3
-
4
-
5
Early Experience of TACE Combined with Atezolizumab plus Bevacizumab for Patients with Intermediate-Stage Hepatocellular Carcinoma beyond Up-to-Seven Criteria: A Multicenter, Singl... by Kang Wang, Hongfei Zhu, Hongming Yu, Yuqiang Cheng, Yan‐Jun Xiang, Zhangjun Cheng, Yang Li, Tao Li, Dongxu Wang, Zhenyu Zhu, Shuqun Cheng
Published 2023Artigo -
6
Oncogenic Akt-FOXO3 loop favors tumor-promoting modes and enhances oxidative damage-associated hepatocellular carcinogenesis by Miao Lu, Daniel Hartmann, Rickmer Braren, Aayush Gupta, Baocai Wang, Yang Wang, Carolin Mogler, Zhangjun Cheng, Thomas Wirth, Helmut Friess, Jörg Kleeff, Norbert Hüser, Yoshiaki Sunami
Published 2019Artigo -
7
Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription by Qinjunjie Chen, Haibo Wang, Zheng Li, Fengwei Li, Leilei Liang, Yiran Zou, Hao Shen, Jun Li, Yong Xia, Zhangjun Cheng, Tian Yang, Kui Wang, Feng Shen
Published 2021Artigo -
8
Risk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection by Zhangjun Cheng, Pinghua Yang, Shuping Qu, Jiahua Zhou, Jue Yang, Xinwei Yang, Yong Xia, Jun Li, Kui Wang, Zhenlin Yan, Dong Wu, Baohua Zhang, Norbert Hüser, Feng Shen
Published 2014Artigo -
9
N<sup>6</sup>-Methyladenosine Modification of ANLN Enhances Hepatocellular Carcinoma Bone Metastasis by Hao Zheng, Zhangjun Cheng, Bo Liang, Zhenguang Wang, Yuan‐Ping Tao, Shengyu Huang, Jun-sheng Ni, Huifen Li, Le Yang, Shengxian Yuan, Jennifer D. Wu, Takumi Kawaguchi, Hrishikesh Samant, Weiping Zhou, Daimin Xiang, Yuan Yang
Published 2023Artigo -
10
An RNA–RNA crosstalk network involving HMGB1 and RICTOR facilitates hepatocellular carcinoma tumorigenesis by promoting glutamine metabolism and impedes immunotherapy by PD-L1+ exo... by Yanping Wei, Xuewu Tang, Yibin Ren, Yun Yang, Fengliang Song, Jingbo Fu, Shuowu Liu, Miao Yu, Jing Chen, Suyang Wang, Kecheng Zhang, Yexiong Tan, Zhipeng Han, Lixin Wei, Baohua Zhang, Zhangjun Cheng, Li Liang, Hongyang Wang
Published 2021Artigo -
11
Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma: a multicenter study from China by Yifan Chen, Hongzhi Liu, Jinyu Zhang, Yijun Wu, Weiping Zhou, Zhangjun Cheng, Jianying Lou, Shuguo Zheng, Xinyu Bi, Jianming Wang, Wei Guo, Fu‐Yu Li, Jian Wang, Yamin Zheng, Jingdong Li, Shi Cheng, Yongyi Zeng, Jingfeng Liu
Published 2021Artigo -
12
Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma by Yong Xia, Jun Li, Guanghua Liu, Kui Wang, Guojun Qian, Zhenhua Lu, Tian Yang, Zhenlin Yan, Zhengqing Lei, Anfeng Si, Xuying Wan, Han Zhang, Chunfang Gao, Zhangjun Cheng, Timothy M. Pawlik, Hongyang Wang, Wan Yee Lau, Mengchao Wu, Feng Shen
Published 2019Artigo
Search Tools:
Related Subjects
Biology
Hepatocellular carcinoma
Medicine
Cancer research
Internal medicine
Gene
Cancer
Carcinogenesis
Cell biology
Signal transduction
Biochemistry
Downregulation and upregulation
Gastroenterology
Genetics
Liver cancer
Oncology
PI3K/AKT/mTOR pathway
Transcription factor
Cirrhosis
Hepatectomy
Immunotherapy
Paleontology
Pathology
Protein kinase B
RNA
Randomized controlled trial
Resection
Stage (stratigraphy)
Surgery
mTORC1